Dabur

Delhi, India Founded: 1884 • Age: 142 yrs Listed Fortune India 500 · #207 India's Most Valuable · #87
Manufacturer of ayurvedic medicine and natural consumer products

About Dabur

Dabur is a publicly listed company based in Delhi (India) founded in 1884. Manufacturer of ayurvedic medicine and natural consumer products. Dabur has raised $42.18 million across 4 funding rounds from investors including Baring Private Equity Partners. The company has 4,770 employees. Dabur has completed 6 acquisitions, including Asian Consumer Care, Badshah Masala and Balsara Home Products. Its chief executive, as recorded, is Mohit Malhotra. Its website dabur.com draws about 388 thousand monthly visits. Its Indian entity Dabur India Limited reported revenue of β‚Ή9,861 Cr. Its focus areas include Consumer Goods, Beauty & Personal Care Products, Multi Category and Natural. Its competitors include Mamaearth, WOW Skin Science and The Body Shop India; 2 of its 3 listed competitors have raised funding.

Company details

Dabur was founded in 1884 in Delhi, India, and operates in the ayurvedic medicine and natural consumer products sector. A diverse portfolio is produced, encompassing skincare, haircare, healthcare, and oral care items. Offerings include hair oil, toothpaste, churna, chyawanprash, honey, rose water, tea, cough syrup, health juices, skin care products, and baby care essentials. Operations focus on traditional formulations for everyday health and personal needs.

Dabur is ranked #207 on the Fortune India 500 (2025) and #87 among India's most valuable companies (2025).

Recognitions & Rankings of Dabur

Fortune India 500 2025 edition
Rank#207
Total income
₹13,171 Cr
Profit
₹1,768 Cr
Last year #193
India's Most Valuable Companies 2025 edition · Source: Hurun India
Rank#87
Valuation
₹78,310 Cr
2024 #79 2023 #43 2022 #40
  • Headquarters Delhi, India
  • Employees 4,770
  • Stage Public
  • Sectors
    Consumer
  • Website category Health
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website dabur.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Dabur India Limited
Key Metrics
  • Market Cap
    ₹67,911 Cr

    DABUR · NSE

  • Share Price
    ₹375.25

    -1.97% today

  • Revenue
    ₹13,193 Cr

    FY 2025-26 · +5.0% YoY

  • EBITDA
    ₹2,435 Cr

    Margin 18.5%

  • Net Profit
    ₹1,888 Cr

    FY 2025-26 · +7.5% YoY

  • P/E (TTM)
    33.1x

    P/B 5.9x

  • ROE
    16.8%

    ROCE 20.9%

  • Debt / Equity
    0.10

    Interest cover 7.4x

  • Total Equity Funding
    $42.18M (USD)

    in 4 rounds

  • Latest Funding Round
    $9.03M (USD), Angel Round

    Mar 2024

  • Investors
  • Employee Count
    4,770
  • Investments & Acquisitions

Apps and channels of Dabur

its YouTube channel DaburIndiaLtd has 5.67K subscribers and 30 videos.

DaburIndiaLtd
YouTube 5.67K subscribers 30 videos Education
Open channel

Videos from Dabur

The most watched videos on Dabur's YouTube channel, DaburIndiaLtd (5.67K subscribers). Click a video to play it here.

Presenting the new TVC for Dabur Glucoplus C! Extra Glucose, Instant Energy.
5.7K views
Dabur Cool King Icy Perfume Talc for 12 Hours Icy Freshness | Ranbir Kapoor | Super Icy Cooling
4.5K views
Mr. Aam TVC | Dabur Hajmola x Kartik Aaryan
2.4K views
Dabur Verve: Sales and Marketing Case Study Competition 2024
1.9K views

More on DaburIndiaLtd.

Funding Insights of Dabur

Dabur has successfully raised a total of $42.18M across 4 strategic funding rounds. The most recent funding activity was a Angel Round of $9.03 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $42.18M
  • Total Rounds 4
  • Last Round Angel Round β€” $9.03M
  • First Round $45M

    (Jun 2012)

  • Investors Count 1

All 4 funding rounds of Dabur with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2024$9.03MAngel Round––
–
Nov 2023$33.16MAngel Round––
–
Apr 2013$18MPost-IPO––
Jun 2012$45MPost-IPO––
Valuation history

1 investors in total: 1 institutional.

Investors in Dabur

Dabur has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Baring Private Equity Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity firm focusing on buyouts and investments in multiple sectors
1998bpepindia.comMumbai, India
Premium access

Investor details for Dabur

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Dabur India Limited (Dabur)

Dabur India Limited is the primary company behind Dabur. The boards of the 6 registered companies of Dabur currently have 25 directors; the longest-serving is Pritam Das Narang, appointed in 1998. 55 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Pritam Das Narang
DIN 00021581
Whole-time director01 Apr 199828 yrs 7 moDabur India Limited
Ashok Kumar Jain
DIN 00042902
Director17 Aug 199927 yrs 2 moDabur Securities Private Limited, Malhotras Trading Co Pvt Ltd
Mohit Burman
DIN 00021963
Director18 Oct 200125 yrsMalhotras Trading Co Pvt Ltd, Dabur India Limited
Amit Burman
DIN 00042050
Director01 Nov 200125 yrsDabur India Limited
Abhay Kumar Agarwal
DIN 00042882
Director25 Jul 200719 yrs 3 moDabur Securities Private Limited
Ajay Kumar Marwah
DIN 00042822
Director20 Aug 200818 yrs 2 moMalhotras Trading Co Pvt Ltd
Ajay Kumar Vij
DIN 00164984
Director16 Dec 200817 yrs 10 moAlthea Drf Lifesciences Limited
Vivek Chand Burman
DIN 00041962
Director01 Jan 201115 yrs 10 moDabur Securities Private Limited, Dabur Ayurvedic Specialities Limited
Anand Chand Burman
DIN 00056216
Director14 Apr 201115 yrs 6 moDabur Securities Private Limited
Saket Burman
DIN 05208674
Director31 Jan 201214 yrs 9 moDabur India Limited
Minnie Burman
DIN 02614903
Director05 Mar 201214 yrs 8 moAlthea Drf Lifesciences Limited
Mohit Malhotra
DIN 08346826
Whole-time director31 Jan 20197 yrs 9 moDabur India Limited
Ajit Mohan Sharan
DIN 02458844
Director31 Jan 20197 yrs 9 moDabur India Limited
Anurag Gupta
DIN 07138649
Director06 Mar 20197 yrs 8 moAlthea Drf Lifesciences Limited
Aditya Chand Burman
DIN 00042277
Director19 Jul 20197 yrs 3 moDabur India Limited
Mukesh Hari Butani
DIN 01452839
Director01 Jan 20215 yrs 10 moDabur India Limited
Rajiv Mehrishi
DIN 00208189
Director01 Sep 20215 yrs 2 moDabur India Limited
Akhil Mahajan
DIN 09288584
Director21 Mar 20224 yrs 7 moDabur Ayurvedic Specialities Limited
Satyavati Berera
DIN 05002709
Director01 Jun 20233 yrs 5 moDabur India Limited
Romesh Sobti
DIN 00031034
Director01 Apr 20242 yrs 7 moDabur India Limited
Ravi Kapoor
DIN 00185981
Director25 Jun 20242 yrs 4 moDabur India Limited
Manu Jaggi
DIN 08351405
Whole-time director24 Dec 20241 yr 10 moAlthea Drf Lifesciences Limited
Nitin Garg
DIN 10085072
Additional Director21 Mar 20251 yr 7 moDabur Ayurvedic Specialities Limited
Sampath Kumar
DIN 11461960
Additional Director27 Jan 20269 moBurman Resorts Private Limited
Sarita Agrawal
DIN 11458219
Additional Director27 Jan 20269 moBurman Resorts Private Limited

People of Dabur

199 people are tracked at Dabur (59 in leadership, 13 in board & advisors, 127 in team); the tracked headcount is 4,770.

NameRoleGroup
OwnerLeadership
CEOLeadership
Ashish Dixit
Unit Operation HeadLeadership
Mandeep Singh Oberoi
Head Of MarketingLeadership
Manas Mehra
Global Chief Information OfficerLeadership
Hrishikesh Ramani
Vice PresidentLeadership
Tobin Pappan
Cluster HeadLeadership
Chandan Agarwal
Head Of TaxLeadership
Biswaranjan Roul
Engineering HeadLeadership
Somit Mukherjee
Senior Vice President (central Procurement & Material Supply Chain) & Chief Procurement OfficerLeadership
Narayanan Renganathan
Vice President & Head Of ProcurementLeadership
Deepak Gupta
Area Sales Head- West ZoneLeadership
Birender Rana
Business HeadLeadership
Rajiv Dubey
Vice President MarketingLeadership
Smerth Khanna
Head - South India And Organised Trade (mt And Ecom).Leadership
Dr Mandeep Singh Oberoi
Head Of MarketingLeadership
Prashant Agarwal
Head Of Marketing - Oral Care At Dabur India LimitedLeadership
Anil Bothra
Vice PresidentLeadership
Ajay Singh Parihar
Vice President - Healthcare & Ayurvedic BusinessLeadership
Ankush Jain
Chief Financial OfficerLeadership

179 more people are available in the full profile.

Premium access

Complete people profiles for Dabur

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Dabur

Dabur is a publicly listed company on the NSE with ticker symbol DABUR in India, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date28 Apr 1999
  • Listed onNSE: DABUR
  • Listed entityDabur India Limited
  • Exchange sectorConsumer non-durables
  • ISININE016A01026
  • Share price₹388.40 (+2.55% on the day) · 2026-10-14
  • Market capitalisation₹67,233 Cr
  • Price to earnings35.0
  • EPS (diluted, trailing year)₹11.10
  • Dividend yield2.18%
  • Volume (last session)2,271,891

Financials of Dabur

Exchange-reported figures of Dabur India Limited, the listed company behind Dabur (NSE: DABUR).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹13,193 Cr
+5.0% YoY
EBITDA
₹2,435 Cr
+5.1% YoY
Profit After Tax
₹1,888 Cr
+7.5% YoY
Net Worth
₹11,420 Cr
+5.7% YoY
Total Assets
₹13,175 Cr
+7.7% YoY
Total Debt
₹1,287 Cr
+35.5% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue13,19312,56312,40411,53010,8899,5628,685
Revenue growth+5.0%+1.3%+7.6%+5.9%+13.9%+10.1%-
EBITDA2,4352,3162,4002,1622,1672,0021,692
EBITDA margin+18.5%+18.4%+19.4%+18.8%+19.9%+20.9%+19.5%
Profit before tax2,4202,2582,3592,2192,2692,0561,728
Net profit1,8881,7561,8421,6951,8031,6931,518
Net profit margin+14.3%+14.0%+14.9%+14.7%+16.6%+17.7%+17.5%
EPS (β‚Ή)10.689.9710.409.649.849.588.18
Balance sheet
Total assets13,17512,23411,74210,6859,5208,2747,232
Net worth11,42010,8019,8668,9738,3817,6646,606
Total debt1,2879501,3651,1741,030509522
Cash & bank5625786663265701,329811
Net working capital1425917416347801,4701,384
Cash flow
Cash from operations2,5791,9872,0131,4881,8022,1151,614
Cash from investing(1,279)(448)(971)(583)(1,273)(1,404)(517)
Cash from financing(1,236)(1,405)(1,161)(1,035)(490)(613)(1,043)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue3,5633,7643,0383,5593,1913,4052,8303,355
Revenue growth (YoY)+11.7%+10.6%+7.4%+6.1%+5.4%+1.7%--
Other income172173175141140144141129
EBITDA632741461719588667427682
EBITDA margin+17.7%+19.7%+15.2%+20.2%+18.4%+19.6%+15.1%+20.3%
Depreciation119121122117115114117109
Interest39.5936.6339.9731.1239.6834.6339.2544.20
Profit before tax646756474711573663412658
Tax14716911215812815499.18142
Net profit499586362554445508313516
EPS (β‚Ή)2.843.332.083.152.552.901.802.94
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue9,3839,0719,1368,6848,1807,1856,310
Revenue growth+3.5%-0.7%+5.2%+6.2%+13.9%+13.9%-
EBITDA1,7661,7071,8391,6711,7341,5591,281
EBITDA margin+18.8%+18.8%+20.1%+19.2%+21.2%+21.7%+20.3%
Profit before tax1,9011,8081,9671,8291,8961,6831,408
Net profit1,4921,4041,5101,3831,4331,3811,240
Net profit margin+15.9%+15.5%+16.5%+15.9%+17.5%+19.2%+19.7%
EPS (β‚Ή)8.417.928.527.758.117.826.62
Balance sheet
Total assets8,2117,8667,7576,9656,4855,6284,784
Net worth7,5277,4236,9156,2875,8645,3914,574
Total debt611379776615560180151
Cash & bank21.6613371.1133.40136835526
Net working capital(1,223)(704)(503)(352)(82.34)503567
Cash flow
Cash from operations1,8851,6231,6531,5621,3201,7041,155
Cash from investing(603)(98.90)(736)(617)(682)(1,120)(330)
Cash from financing(1,293)(1,511)(922)(940)(635)(555)(826)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue2,4332,6872,1322,5472,2352,4701,9652,448
Revenue growth (YoY)+8.9%+8.8%+8.5%+4.1%+4.3%-1.8%--
Other income128131147108106116119105
Total expenses1,9742,1521,8152,0071,8111,9841,6801,926
EBITDA459536317540424485284523
EBITDA margin+18.9%+19.9%+14.9%+21.2%+19.0%+19.6%+14.5%+21.3%
Depreciation65.7467.0867.2666.2564.1363.1963.2263.78
Interest26.5021.7223.2722.1619.6017.2822.8428.33
Profit before tax495578374560447521317536
Tax10712577.8912098.0611366.17118

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 09 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue3,5633,7643,0383,5593,1913,4052,8303,355
Revenue growth (YoY)+11.7%+10.6%+7.4%+6.1%+5.4%+1.7%--
Other income172173175141140144141129
EBITDA632741461719588667427682
EBITDA margin+17.7%+19.7%+15.2%+20.2%+18.4%+19.6%+15.1%+20.3%
Depreciation119121122117115114117109
Interest39.5936.6339.9731.1239.6834.6339.2544.20
Profit before tax646756474711573663412658
Tax14716911215812815499.18142
Net profit499586362554445508313516
EPS (β‚Ή)2.843.332.083.152.552.901.802.94
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue13,19312,56312,40411,53010,8899,5628,685
Revenue growth+5.0%+1.3%+7.6%+5.9%+13.9%+10.1%-
Other income600551482445393325305
Total expenses10,75810,24710,0049,3678,7227,5606,992
Employee cost1,3761,2911,2401,1371,0801,033948
EBITDA2,4352,3162,4002,1622,1672,0021,692
EBITDA margin+18.5%+18.4%+19.4%+18.8%+19.9%+20.9%+19.5%
Depreciation469446399311253240220
Interest14516412478.2438.6030.8149.54
Profit before tax2,4202,2582,3592,2192,2692,0561,728
Tax552517547517526361280
Net profit1,8881,7561,8421,6951,8031,6931,518
Net profit margin+14.3%+14.0%+14.9%+14.7%+16.6%+17.7%+17.5%
EPS (β‚Ή)10.689.9710.409.649.849.588.18
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital177177177177177177177
Reserves & surplus11,24210,6239,6898,7968,2057,4876,429
Shareholders' funds (net worth)11,42010,8019,8668,9738,3817,6646,606
Minority interest38341043746840.5536.6936.46
Secured loans7143384471988.6344.21136
Unsecured loans5736129189761,021465386
Total debt1,2879501,3651,1741,030509522
Total liabilities13,17512,23411,74210,6859,5208,2747,232
Assets
Gross block7,1616,7566,2155,5834,0413,7793,629
Net block3,9383,9903,8153,5792,3082,2432,253
Capital work in progress139169232175168147147
Investments8,9477,4686,9336,2656,2204,1602,800
Inventories2,3222,3001,9472,0241,9111,7341,380
Sundry debtors715888899849646562814
Cash & bank balances5625786663265701,329811
Loans & advances691678501314334405484
Total current assets4,2904,4454,0133,5123,4624,0303,489
Total current liabilities4,1493,8543,2722,8792,6822,5592,105
Net working capital1425917416347801,4701,384
Total assets13,17512,23411,74210,6859,5208,2747,232
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash112(21.18)97.5722718991.7437.72
Net cash from operating activities2,5791,9872,0131,4881,8022,1151,614
Net cash from investing activities(1,279)(448)(971)(583)(1,273)(1,404)(517)
Net cash from financing activities(1,236)(1,405)(1,161)(1,035)(490)(613)(1,043)
Net change in cash63.71133(119)(130)38.3997.0454.02
Closing cash5625786663265701,329811
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+5.0%+1.3%+7.6%+5.9%+13.9%+10.1%-
EBITDA growth+5.1%-3.5%+11.0%-0.2%+8.3%+18.3%-
PBT growth+7.2%-4.3%+6.3%-2.2%+10.3%+19.0%+0.2%
Net income growth+7.5%-4.7%+8.7%-6.0%+6.5%+11.5%-
Revenue CAGR (3Y)+4.6%+4.9%+9.1%+9.9%+8.5%+7.4%+4.5%
EBITDA CAGR (3Y)+4.0%+2.3%+6.2%+8.5%+9.2%+7.7%+3.9%
Profitability & leverage
Net income margin+14.2%+13.9%+14.6%+14.8%+16.0%+17.7%+16.7%
Return on capital employed+20.9%+20.9%+23.1%+23.3%+26.1%+27.0%+26.2%
Return on net worth+16.8%+16.8%+19.2%+19.6%+21.7%+23.8%+23.7%
Debt / equity0.100.110.130.130.100.070.10
Long-term debt / equity0.030.060.060.050.030.020.02
Interest cover7.408.746.214.232.021.753.37
Efficiency & per share
Fixed asset turnover1.901.942.102.402.782.582.57
Inventory turnover5.715.926.255.865.976.146.49
Debtors turnover16.4514.0614.2015.4318.0313.9010.57
EPS (β‚Ή)10.689.9710.409.649.849.588.18
Dividend per share (β‚Ή)8.258.005.505.205.204.753.00
Book value per share (β‚Ή)64.3860.9455.6850.6447.4143.3637.38
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue2,4332,6872,1322,5472,2352,4701,9652,448
Revenue growth (YoY)+8.9%+8.8%+8.5%+4.1%+4.3%-1.8%--
Other income128131147108106116119105
Total expenses1,9742,1521,8152,0071,8111,9841,6801,926
EBITDA459536317540424485284523
EBITDA margin+18.9%+19.9%+14.9%+21.2%+19.0%+19.6%+14.5%+21.3%
Depreciation65.7467.0867.2666.2564.1363.1963.2263.78
Interest26.5021.7223.2722.1619.6017.2822.8428.33
Profit before tax495578374560447521317536
Tax10712577.8912098.0611366.17118
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue9,3839,0719,1368,6848,1807,1856,310
Revenue growth+3.5%-0.7%+5.2%+6.2%+13.9%+13.9%-
Other income478452418392342277277
Total expenses7,6177,3647,2977,0136,4465,6265,029
Employee cost814777782726679656578
EBITDA1,7661,7071,8391,6711,7341,5591,281
EBITDA margin+18.8%+18.8%+20.1%+19.2%+21.2%+21.7%+20.3%
Depreciation261251209188160143130
Interest82.3199.5881.1446.3718.679.1419.27
Profit before tax1,9011,8081,9671,8291,8961,6831,408
Tax409405457455463301238
Net profit1,4921,4041,5101,3831,4331,3811,240
Net profit margin+15.9%+15.5%+16.5%+15.9%+17.5%+19.2%+19.7%
EPS (β‚Ή)8.417.928.527.758.117.826.62
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital177177177177177177177
Reserves & surplus7,3497,2466,7386,1105,6875,2144,398
Shareholders' funds (net worth)7,5277,4236,9156,2875,8645,3914,574
Secured loans1960.1099.991780.0026.94101
Unsecured loans41537967643856015349.46
Total debt611379776615560180151
Total liabilities8,2117,8667,7576,9656,4855,6284,784
Assets
Gross block3,9623,7223,3452,9382,5012,1681,982
Net block2,0512,0361,8781,6621,3991,2051,134
Capital work in progress110137184109128107106
Investments7,2486,3596,1485,4755,0073,5742,467
Inventories1,3651,2881,1501,2241,2381,114809
Sundry debtors473601719561455281380
Cash & bank balances21.6613371.1133.40136835526
Loans & advances334280232140126149168
Total current assets2,1932,3022,1721,9591,9552,3791,883
Total current liabilities3,4163,0062,6752,3112,0371,8761,316
Net working capital(1,223)(704)(503)(352)(82.34)503567
Total assets8,2117,8667,7576,9656,4855,6284,784
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash24.1610.7715.3510.477.01(21.75)(20.24)
Net cash from operating activities1,8851,6231,6531,5621,3201,7041,155
Net cash from investing activities(603)(98.90)(736)(617)(682)(1,120)(330)
Net cash from financing activities(1,293)(1,511)(922)(940)(635)(555)(826)
Net change in cash(10.63)13.39(4.58)4.883.4628.76(1.51)
Closing cash21.6613371.1133.40136835526
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+3.5%-0.7%+5.2%+6.2%+13.9%+13.9%-
EBITDA growth+3.5%-7.2%+10.1%-3.6%+11.2%+21.7%-
PBT growth+5.1%-8.1%+7.6%-3.6%+12.7%+19.5%-6.3%
Net income growth+6.3%-7.0%+9.2%-3.5%+3.8%+11.4%-
Revenue CAGR (3Y)+2.6%+3.5%+8.3%+11.2%+9.3%+8.7%+6.1%
EBITDA CAGR (3Y)+1.9%-0.5%+5.7%+9.3%+8.2%+8.7%+4.8%
Profitability & leverage
Net income margin+15.9%+15.5%+16.5%+15.8%+17.5%+19.2%+18.6%
Return on capital employed+24.7%+24.4%+27.8%+27.9%+31.6%+32.5%+31.3%
Return on net worth+20.0%+19.6%+22.9%+22.6%+25.5%+27.7%+27.4%
Debt / equity0.070.080.110.100.070.030.05
Long-term debt / equity0.030.060.060.050.030.000.01
Interest cover5.476.844.983.131.190.651.67
Efficiency & per share
Fixed asset turnover2.442.572.913.193.503.463.36
Inventory turnover7.077.447.707.066.967.478.18
Debtors turnover17.4813.7514.2717.1022.2321.7415.56
EPS (β‚Ή)8.417.928.527.758.117.826.62
Dividend per share (β‚Ή)8.258.005.505.205.204.753.00
Book value per share (β‚Ή)42.4441.8939.0335.4833.1730.5025.89

Investments & Acquisitions by Dabur

Dabur has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Asian Consumer Care, Badshah Masala and Balsara Home Products.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Ayurvedic hair care and wellness products are manufactured naturally.
sesacare.comThane, India1995Oct 2024$1.5M
Blended, ground, and whole spices are manufactured for culinary applications.
badshahmasala.comMumbai, India1958Oct 2022$18.77M
Retailer of personal care products
0Jul 2022β€’β€’β€’β€’
Hair care products are developed and marketed for renewal needs.
orshaircare.comChicago, United States1996Nov 2010$100M
Manufacturer of hair, body, and skin care products
hobikozmetik.comIstanbul, Turkey1974Jul 2010$69.84M
Telecommunication industry products are provided by Balsara Home Products.
balsara.comMumbai, India1925Jan 2005β€’β€’β€’β€’
Premium access

Complete acquisition details for Dabur

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Dabur

10 dated milestones of Dabur across 140 years, from founding to its latest funding, stage changes and deals.

  1. Founded Dabur is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Balsara Home Products.
  4. Acquisition Acquires Hobi Kozmetik.
  5. Acquisition Acquires ORS Hair Care.
  6. Funding First funding round of $45.0M.
  7. Acquisition Acquires Asian Consumer Care.
  8. Acquisition Acquires Badshah Masala.
  9. Funding Latest funding round, Angel Round, of $9.0M.
  10. Acquisition Acquires Sesa Care.

Competitors of Dabur

Dabur has 3 listed competitors in our database, 2 of them funded. They include Mamaearth, WOW Skin Science and The Body Shop India.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
mamaearth.in2016Gurugram, India$89.36M1,900
Online brand offering multi-category natural skin care and makeup products
buywow.in2014Bengaluru, India$98M100
Organic beauty products are offered by an internet-first brand.
thebodyshop.in2006Gurugram, India861
Cruelty-free beauty and body care products are retailed in India.
Premium access

Detailed competitors of Dabur

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Dabur

The website of Dabur (dabur.com) receives about 387.5K visits a month and ranks #143,847 among all websites worldwide, #4,403 in Health.

  • Monthly visits
    387.5K

    ▲ 25.1% vs previous month

  • Unique visitors
    112.9K

    per month

  • Global rank
    #143,847

    among all websites

  • Category rank
    #4,403

    Health · Health

Similar websites

Websites whose visitors overlap most with Dabur. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cipla.com
100%
200.9K#203,362View details
drreddys.com
98%
118.8K#308,607View details
baidyanath.com
88%
View details
zanduayurveda.com
85%
View details
himalayahealthcare.com
85%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Dabur

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Beauty & Personal Care Products

3 companies that operate in the same segment as Dabur (Beauty & Personal Care Products) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Online platform offering a wide range of baby, kids, and maternity products
2010Pune, Maharashtra, IndiaUSD 513.39 MUSD 911.07 M3,752
Online brand offering mens grooming products
2015Gurugram, Haryana, IndiaUSD 52.66 M
Retailer of perfumes, cosmetics, skincare, and related gift set items
2012Gurugram, Haryana, IndiaUSD 60.63 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Dabur

Dabur: Jefferies on Dabur maintains Buy, Target Price cut to Rs 535; Domestic volumes remained broadly steady and international growth was strong, but margins missed estimates due to higher operating expenses. HPC and Foods performed well, while Healthcare faced regulatory challenges. Jefferies flagged the upcoming leadership transition following CEO Mohit Malhotra’s resignation and awaits management commentary on strategy and outlook.
Exchange Update β€’ 4 days ago
Dabur: HSBC on Dabur maintains Hold, Target Price Rs 426; Q2FY27 revenue was in line, while EBITDA came in 1–2% below consensus. India FMCG volume growth stood at 5.5%. CEO Mohit Malhotra will resign effective November 13, with India CEO Herjit Singh Bhalla continuing in his role.
Exchange Update β€’ 4 days ago
Dabur: Citi on Dabur maintains Sell, Target Price Rs 380; Q2 revenue, EBITDA and recurring PAT grew 12%, 8% and 11% YoY, respectively, with domestic growth supported almost equally by volumes and pricing or mix. Performance was broad-based across segments, while premium brands now contribute 20% of domestic business. Citi will monitor whether the CEO transition leads to any changes in strategic priorities.
Exchange Update β€’ 4 days ago
DABUR: CO DECLARED AN INTERIM DIVIDEND OF RS. 3.50 PER EQUITY SHARE
Exchange Update β€’ 5 days ago
DABUR: Q2 REVENUE 35.63B RUPEES VS 31.91B (YOY)
Exchange Update β€’ 5 days ago
DABUR: Q2 CONS NET PROFIT 5.05B RUPEES VS 4.52B (YOY); EST 5B
Exchange Update β€’ 5 days ago
DABUR: Q2 EBITDA 6.31B RUPEES VS 5.88B (YOY); Q2 EBITDA MARGIN 17.73% VS 18.43% (YOY)
Exchange Update β€’ 5 days ago
Dabur: Nomura on Dabur Buy, Target Price ₹625; expects 2Q consolidated revenue growth of 12.5% YoY, with India sales growth returning to double digits after 19 quarters, supported by a sharp beverages recovery; elevated HPC and OTC & Ethicals input costs to be partly offset by calibrated pricing and cost-saving initiatives.
Exchange Update β€’ 1 month ago
Dabur: Goldman Sachs on Dabur Maintains Buy, Target Price ₹625; double-digit growth sustained, though EBITDA margin is expected to moderate marginally YoY, while sequential business improvement and a soft/favourable base in coming quarters support the outlook.
Exchange Update β€’ 1 month ago
Premium access

Complete news archive for Dabur

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Articles about Dabur on our blog

Frequently Asked Questions about Dabur

Dabur was founded in 1884 and raised its 1st funding round 128 years after it was founded.

Dabur is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Mohit Malhotra is the CEO of Dabur, as recorded in our data.

Dabur is a funded company, having raised a total of $42.18M across 4 funding rounds to date. The company's 1st funding round was a Post-IPO of $45M, raised on Jun 2012.

Dabur has 4,770 employees.

The primary company behind Dabur, Dabur India Limited, reported revenue of β‚Ή9,861 Cr for FY 2026, up 5% year on year.

Dabur was founded in 1884 in Delhi, India, and operates in the ayurvedic medicine and natural consumer products sector. A diverse portfolio is produced, encompassing skincare, haircare, healthcare, and oral care items. Offerings include hair oil, toothpaste, churna, chyawanprash, honey, rose water, tea, cough syrup, health juices, skin care products, and baby care essentials. Operations focus on traditional formulations for everyday health and personal needs.

Dabur's top competitors include Mamaearth, The Body Shop India and WOW Skin Science.

Yes, Dabur is publicly traded on NSE under the ticker symbol DABUR.

Dabur has made 6 acquisitions, including Asian Consumer Care, Badshah Masala, and Balsara Home Products.

Dabur has 1 investor. Key investors include Baring Private Equity Partners.

Dabur is associated with 6 legal entities: Dabur India Limited, Dabur Securities Private Limited, Malhotras Trading Co Pvt Ltd and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available